It is noteworthy that increased amount of tumor PKM2 has also been reported in the tumor cells and EDTA plasma of patients with cancers of the kidney, lung, breast, cervical and gastrointestinal tract, as well as in stool samples of patients with colorectal and stomach cancer [21]. This evidence concerns the gene PKM and gastric neoplasm.